Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Choi, San Diego
Ada Saulai Choi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110066965 | ELECTRONIC BOOK WITH ENHANCED FEATURES - An electronic book allows a user to select portions of text from an electronic book file and copies the portions into a summary document, ordering the portions in the summary document in the same order the portions appeared in the book. The portions can be accompanied by page numbers or links to the book from which they came so that a user can easily refer back to the book at a location corresponding to an interesting entry in the summary document. | 03-17-2011 |
Ha-Soon Choi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080287516 | Phenyl-Substituted Pyrrolidones - The present invention relates to phenyl-substituted pyrrolidones and compounds related to phenyl-substituted pyrrolidones. One use of these compounds is for the inhibition of viruses, e.g., HIV. The invention further relates to methods of malting these compounds, methods of identifying the efficacy of these compounds, and methods of using these compounds to inhibit or prevent HIV infection and related disease states such as AIDS. | 11-20-2008 |
| 20090247517 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). | 10-01-2009 |
| 20100048552 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, Bcr-Abl, Bcr-Abl(T315I), ALK, BLK, BMX, BRK, C-kit, c-RAF, CSK, c-SRC, EGFR, Fes, FGFR3, Flt3, Fms, Fyn, IGF-1R, IR, JAK(2), JAK(3), KDR, Lck, NLK, p70S6K, PDGFRα, Ros, SAPK2α, SGK, SIK, Syk, Tie2 and TrkB kinases. | 02-25-2010 |
| 20100168182 | COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly TrkA, TrkB, TrkC, PDGFR and c-kit. | 07-01-2010 |
| 20110166133 | FUSED NITROGEN CONTAINING HETEROCYCLES AND COMPOSITIONS THEREOF AS KINASE INHIBITORS - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Ros, KDR, FMS, C-FMS, FLT3, c-Kit, JAK2, JAK3, Aurora, PDGFR, Lck, TrkA, TrkB, TrkC, IGF-IR, ALK4, ALK5 and ALK or combinations thereof. | 07-07-2011 |
Jae-Hee Choi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100034385 | COMBINATIONAL COMBINER CRYPTOGRAPHIC METHOD AND APPARATUS - Another feature provides an efficient encryption method that safeguards the security of encrypted symbols. Each plaintext symbol is encrypted by using a separate pseudorandomly selected translation table. Rather than pre-storing every possible permutation of symbols as translation tables, the translation tables may be efficiently generated on-the-fly based on a pseudorandom number arid a symbol shuffling algorithm. A receiving device may similarly generate reverse translation tables on-the-fly to decrypt received encrypted symbols. | 02-11-2010 |
Jin Sun Karoline Choi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090036434 | Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto - The present invention relates to certain substituted aryl and heteroaryl derivative of Formula (I) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and complications thereof, such as, diabetes and obesity. | 02-05-2009 |
| 20100004264 | PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - Pyrazole derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the serotonin 5HT | 01-07-2010 |
| 20100093761 | FUSED-ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO - The present invention relates to certain fused aryl and heteroaryl derivatives of Formula (I) that are modulators of metabolism. | 04-15-2010 |
| 20110082134 | 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia - The present invention relates to certain 1,2,3-trisubstituted aryl and heteroaryl derivatives of Formula (Ia) that are modulators of metabolism. | 04-07-2011 |
| 20110105456 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention relates to certain 3-phenyl-pyrazole derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT | 05-05-2011 |
| 20110112060 | 1,2,3-TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO - The present invention relates to certain trisubstituted aryl and heteroaryl derivatives of Formula (I) that are modulators of metabolism. | 05-12-2011 |
Juyi Choi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090197935 | PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO - The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT | 08-06-2009 |
Michael J. Choi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100056505 | Substituted Pyrazalones - The invention is related to compounds of formula (I) as antagonists of the TGFβ family type I receptors, Alk5 and/or AIk 4, compositions and methods of use. The compounds of formula (I) can be employed in the prevention and/or treatment of diseases such as fibrosis (e.g., renal fibrosis, pulmonary fibrosis, and hepatic fibrosis), progressive cancers, or other diseases for which reduction of TGFβ family signaling activity is desirable. | 03-04-2010 |
Sungwook Choi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090197861 | INHIBITORS OF INTEGRIN ALPHA2BETA1 WITH MODIFIED UREA MOIETY - Novel compounds inhibiting the integrin α2β1/GPIa-IIa receptor are disclosed. Also disclosed are pharmaceutical compositions containing the compounds, as well as methods of their therapeutic use. The compounds disclosed are useful, inter alia, as inhibitors of integrin α2β1/GPIa-IIa-mediated activity. | 08-06-2009 |
| 20100179119 | Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold - Novel compounds inhibiting the integrin α2β1/GPIa-IIa receptor are disclosed. Also disclosed are pharmaceutical compositions containing the compounds, as well as methods of their therapeutic use. The compounds disclosed are useful, inter alia, as inhibitors of integrin α2β1/GPIa-IIa-mediated activity. | 07-15-2010 |
Zae Yong Choi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100172395 | MULTI-CARRIER TRANSMITTER DESIGN ON ADJACENT CARRIERS IN A SINGLE FREQUENCY BAND ON THE UPLINK IN W-CDMA/HSPA - Systems and methodologies are described that facilitate synthesizing a single baseband waveform from digital signals related to multiple carriers. Digital signals can be received relating to a plurality of carriers. The digital signals can result from spreading data symbols from transport blocks to create chip sequences, which can additionally be pulse shaped. The digital signals can be rotated in a positive or negative direction, such as according to a complex sinusoid or a negative representation thereof. The rotated signals can be combined or added to generate a single baseband waveform. The single baseband waveform can be converted to an analog signal, which can be up-converted and centered at a plurality of frequency carriers, which can be adjacent, assigned for transmitting the signal. In addition, optimizations can be provided to ensure threshold power ratio over the plurality of carriers for effectively transmitting jointly encoded signals. | 07-08-2010 |